CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($) $ in Millions		Dec. 31, 2023	Sep. 30, 2023
Current assets
Cash and cash equivalents		$ 440	$ 417
Accounts receivable - Note G	[1]	194	338
Inventories - Note F		588	626
Other assets		143	125
Total current assets		1,365	1,506
Property, plant and equipment
Cost		3,277	3,211
Accumulated depreciation		1,910	1,838
Net property, plant and equipment		1,367	1,373
Goodwill - Note F		1,396	1,362
Intangibles - Note F		875	886
Operating lease assets, net - Note H		123	122
Restricted investments - Note D		315	290
Asbestos insurance receivable - Note K	[2]	124	127
Deferred income taxes		45	22
Other assets		256	251
Total noncurrent assets		4,501	4,433
Total assets		5,866	5,939
Current liabilities
Short-term debt - Note G		0	16
Trade and other payables		202	210
Accrued expenses and other liabilities		190	208
Current operating lease obligations - Note H		22	22
Total current liabilities		414	456
Noncurrent liabilities
Long-term debt - Note G		1,341	1,314
Asbestos litigation reserve - Note K		412	427
Deferred income taxes		148	148
Employee benefit obligations - Note J		98	100
Operating lease obligations - Note H		107	106
Other liabilities		293	291
Total noncurrent liabilities		2,399	2,386
Commitments and contingencies - Note K
Stockholders' equity - Note M		3,053	3,097
Total liabilities and stockholders' equity		$ 5,866	$ 5,939

[1] Accounts receivable includes an allowance for credit losses of $3 million at both December 31, 2023 and September 30, 2023.

[2] Asbestos insurance receivable includes an allowance for credit losses of $2 million at both December 31, 2023 and September 30, 2023.